Immune checkpoint inhibitor‐induced myasthenia gravis, myocarditis, and myositis: A case report

Key Clinical Message Immune checkpoint inhibitors can rarely lead to occurrence of myositis, myocarditis, and myasthenia gravis (MG). Early recognition and multidisciplinary management are crucial for optimal outcomes. Vigilance for overlapping toxicities is essential in patients receiving combinati...

Descripció completa

Dades bibliogràfiques

Autors principals:	Arjun Basnet, Nava Raj Sharma, Sudarshan Gautam, Saral Lamichhane, Sajog Kansakar, Kripa Tiwari, Madalasa Pokhrel, Sehajpreet Singh
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2024-06-01
Col·lecció:	Clinical Case Reports
Matèries:	immune checkpoint inhibitors myasthenia myocarditis myositis
Accés en línia:	https://doi.org/10.1002/ccr3.8968
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!